Strengthening Tuberculosis Control in Ukraine: Evaluation of the Impact of the TB-HIV Integration Strategy on Treatment OutcomesDownload Document: tre-18-013-1.pdf (3 MB)Citation: MEASURE Evaluation. (2018). Strengthening Tuberculosis Control in Ukraine: Evaluation of the Impact of the TB-HIV Integration Strategy on Treatment Outcomes. Chapel Hill, NC, USA: MEASURE Evaluation, University of North Carolina.Abstract: Ukraine is one of 30 countries with the highest tuberculosis (TB) burdens in the world, and one of 10 countries with the highest incidence of multidrug-resistant TB, making it one of the highest priority countries in the World Health Organization European Region to fight TB. About one quarter of all patients with TB in Ukraine are estimated to also to be HIV-positive. The treatment of TB-HIV coinfections is particularly challenging as TB becomes more virulent in the presence of HIV-associated immunosuppression. Given the complexities of treating coinfected patients, HIV and TB diagnostic and treatment regimens need to be closely aligned: specialized services for patients with coinfections need to be readily available at AIDS centers and TB dispensaries. Strengthening Tuberculosis Control in Ukraine (StbCU)a project funded by the United States Agency for International Development (USAID)aimed to strengthen the delivery of TB and HIV services, with the goal of improving timeliness of care and enhancing the life expectancy of patients with TB-HIV coinfections. The USAID mission in Ukraine commissioned MEASURE Evaluationfunded by USAID and the United States Presidents Emergency Plan for AIDS Reliefto conduct an impact evaluation of the STbCU project. This report discusses the evaluation and findings. Access a related workshop report to disseminate the findings. Also available in Ukrainian.Shortname: tre-18-013Author(s): Zulfiya Charyeva, Smisha Agarwal, Kristen Brugh, Sin L. Curtis, Stephanie MullenYear: 2018Language: EnglishFiled under: HIV, HIV/AIDS, TB, Tuberculosis, Ukraine
